_1777011671128_85597701.png&w=64&q=75){kind=small}
Moroccan cannabis medicine effective in Italy
Moroccan pharmaceutical industry has successfully developed the first treatment specifically for epilepsy that uses cannabidiol extracted from legally cultivated cannabis in Morocco. The product was showcased at the CPHI exhibition in Milan between October 6 and 8. The medication is based on research demonstrating its effectiveness in treating severe forms of epilepsy that are resistant to conventional therapies. This achievement reflects Morocco’s shift toward transforming cannabis production from raw export to manufacturing high-value-added pharmaceutical products. It is expected that this milestone will open international horizons for Morocco, positioning it as a regional player in the legal medical cannabis market through the integration of agriculture, manufacturing, and scientific research.
Notice: This Is an AI-Generated Summary
Comments (0)